Similar articles

• [Depot antipsychotics in the year 2011].

  Knegtering H, Oolders H, Ruijsink MA, van der Moolen AE. Knegtering H, et al. Tijdschr Psychiatr. 2011;53(2):95-105. Tijdschr Psychiatr. 2011. PMID: 21319066 Review. Dutch.
• Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.

  Turner MS, Stewart DW. Turner MS, et al. J Psychopharmacol. 2006 Nov;20(6 Suppl):20-37. doi: 10.1177/1359786806071243. J Psychopharmacol. 2006. PMID: 17046985 Review.
• Mental health nursing. Depot drugs in community psychiatry.

  Thomas B. Thomas B. Nurs Times. 1984 Jan 18-24;80(3):43-6. Nurs Times. 1984. PMID: 6142448 No abstract available.
• The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.

  Dencker SJ. Dencker SJ. J Clin Psychiatry. 1984 May;45(5 Pt 2):22-7. J Clin Psychiatry. 1984. PMID: 6143744
• Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.

  Diatta T, Blazejewski S, Portier A, Lignot S, Quesnot A, Moore N, Fourrier-Réglat A. Diatta T, et al. Fundam Clin Pharmacol. 2007 Aug;21(4):371-8. doi: 10.1111/j.1472-8206.2007.00492.x. Fundam Clin Pharmacol. 2007. PMID: 17635175